Skip To Main Content
Kunal Sindhu on Muck Rack

Kunal Sindhu

  • Contributor and Assistant Professor, Radiation Oncology, Freelance
New York
As seen in: Color Research & Application, HuffPost, Nature, Wiley, Wiley Online Library, NBC News, New York Daily News, Oxford University Press (OUP), ScienceDirect, BMJ Open Sport & Exercise Medicine and
Covers:  Health, policy
Radiation oncologist @MountSinaiRO | @Lakers fan | Tweets/RTs are not medical advice | Views mine

Get in touch with Kunal

Contact Kunal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Kunal Sindhu’s Biography

Read Full Bio →

Physician. Interested in the intersection of politics and health care, among other topics.

Kunal Sindhu’s Journalist Portfolio

See all →
Multi-Course Reirradiation in Diffuse Intrinsic Pontine Glioma

Multi-Course Reirradiation in Diffuse Intrinsic Pontine Glioma

Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive, invasive, and fatal brainstem tumor that orig…

View article →
Pathologic Response After Neoadjuvant Chemoimmunotherapy in Head and Neck Squamous Cell Carcinoma

Pathologic Response After Neoadjuvant Chemoimmunotherapy in Head and Neck Squamous Cell Carcinoma

View article →
Structural Vulnerability in the United States Radiation Oncology Delivery System: Predictors and ...

Structural Vulnerability in the United States Radiation Oncology Delivery System: Predictors and ...

We sought to identify predictors of radiation oncology (RO) practice site disappearance in the United States …

View article →
Post-treatment circulating tumor DNA clinical features, prognosis in HPV-positive oropharynx cancer

Post-treatment circulating tumor DNA clinical features, prognosis in HPV-positive oropharynx cancer

View article →
Radiotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: Current Evidence and Future Direct...

Radiotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: Current Evidence and Future Direct...

Introduction: Non-muscle-invasive bladder cancer (NMIBC) represents approximately 78% of newly diagnosed blad…

View article →
In Regard to Mehta et al

In Regard to Mehta et al

We read with great interest the article by Mehta et al1 and commend the authors for executing a complex, phas…

View article →

Articles

Time to evolve? Modernizing the hospital ethics committee

|
By Julie Bloom Verified, Kunal Sindhu
| Wiley Online Library Verified
PERSPECTIVES IN HOSPITAL MEDICINE Time to evolve? Modernizing the hospital ethics committee Julie R. Bloom MD, Corresponding Author Julie R. Bloom MD Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Correspondence Julie R. Bloom, MD, Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, 1184 5th Ave, New York, NY 10029, USA.
Open in Who Shared Issue with article?

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care

|
By Kunal Sindhu, Zachary Dovey, Anthony D. Nehlsen, Karin A. Skalina
| BJU International Journal Verified
1 INTRODUCTION According to CDC statistics, in the United States, over 300 000 urological cancers have been diagnosed each year since 2013, and 1 in 3 cancers in all men are urological in origin.
Open in Who Shared Issue with article?

Reirradiation with Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial

|
By Alexandra Hotca, Kunal Sindhu, Eric J. Lehrer, William Hartsell
| Advances in Radiation Oncology Verified
1. Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6). 10.1007/s12328-020-01237-x 2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48. https://doi.org/10.3322/caac.21763 3. Eyck BM, van Lanschot JJB, Hulshof MCCM, et al. Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.
Open in Who Shared Issue with article?
See all 81 licensed articles (85 Total)